Inventor

STEPHEN D. LOTESTA

Inventor

Overview

4→

Patents

2022–2025

Patent span

Human necessities

Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes25%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%

C07DHeterocyclic compounds25%

C07BGeneral methods of organic chemistry13%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium13%

PatentTitleYear

12,312,359Inhibitors of the menin-MLL interaction2025 11,739,085Inhibitors of the menin-MLL interaction2023 11,535,614Dihydropyrrolopyridine inhibitors of ROR-gamma2022 11,479,557Inhibitors of the menin-MLL interaction2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to VITAE PHARMACEUTICALS LLC (4)· patent assignee history

2022–2025Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
VITAE PHARMACEUTICALS LLC	4	2022–2025

Locations

Location	Patents	Span
US	4	2022–2025